Unión Europea -
danés -
EMA (European Medicines Agency)
grasustek
juta pharma gmbh - pegfilgrastim - neutropeni - immunostimulants, - reduktion i varigheden af neutropeni og forekomst af febril neutropeni hos voksne patienter behandlet med cytotoksisk kemoterapi for malignitet (med undtagelse af kronisk myeloid leukæmi og myelodysplastisk syndromer).
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
gefitinib "stada" 250 mg filmovertrukne tabletter
stada arzneimittel ag - gefitinib - filmovertrukne tabletter - 250 mg
Unión Europea -
danés -
EMA (European Medicines Agency)
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - bryst neoplasmer - antineoplastiske midler - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
Unión Europea -
danés -
EMA (European Medicines Agency)
stimufend
fresenius kabi deutschland gmbh - pegfilgrastim - neutropeni - immunostimulants, , koloni-stimulerende faktorer - reduktion i varigheden af neutropeni og forekomst af febril neutropeni hos voksne patienter behandlet med cytotoksisk kemoterapi for malignitet (med undtagelse af kronisk myeloid leukæmi og myelodysplastisk syndromer).
Unión Europea -
danés -
EMA (European Medicines Agency)
teslascan
ge healthcare as - mangafodipir trinatrium - mr scanning - kontrastmedier - dette lægemiddel er kun til diagnostisk brug. kontrastmiddel til diagnostisk magnetisk resonans imaging (mri) til påvisning af læsioner i leveren, der mistænkes for at være på grund af metastatisk sygdom eller hepatocellulært karcinom. som et supplement til mr-at en støtte i undersøgelsen af fokale læsioner i bugspytkirtlen.
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
capthydro 50+25 mg tabletter
sandoz gmbh - captopril, hydrochlorthiazid - tabletter - 50+25 mg
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
captopril/hydrochlorthiazid "ratiopharm" 25+12,5 mg tabletter
ratiopharm gmbh - captopril, hydrochlorthiazid - tabletter - 25+12,5 mg
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
captopril/hydrochlorthiazid "ratiopharm" 50+25 mg tabletter
ratiopharm gmbh - captopril, hydrochlorthiazid - tabletter - 50+25 mg
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
ezetimib/simvastatin "klinge pharma" 10+10 mg tabletter
klinge pharma gmbh - ezetimib, simvastatin - tabletter - 10+10 mg
Dinamarca -
danés -
Lægemiddelstyrelsen (Danish Medicines Agency)
ezetimib/simvastatin "klinge pharma" 10+20 mg tabletter
klinge pharma gmbh - ezetimib, simvastatin - tabletter - 10+20 mg